LONG-TERM TREATMENT OF POLYMYALGIA-RHEUMATICA WITH DEFLAZACORT

被引：26

作者：

CIMMINO, MA ^{[1
]}

MOGGIANA, G ^{[1
]}

MONTECUCCO, C ^{[1
]}

CAPORALI, R ^{[1
]}

ACCARDO, S ^{[1
]}

机构：

[1] IRCCS,POLICLIN SAN MATTEO,IST PATOL MED,PAVIA,ITALY

来源：

ANNALS OF THE RHEUMATIC DISEASES | 1994年 / 53卷 / 05期

关键词：

D O I：

10.1136/ard.53.5.331

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives-To evaluate the long term efficacy and tolerability of deflazacort, a corticosteroid reputed to have only minor side effects, in the treatment of polymyalgia rheumatica (PMR). Methods-In a prospective open study, deflazacort was administered at an average initial dose of 21.8 mg/day for a mean period of 19 months in 40 patients with PMR. Results-A highly significant improvement of clinical and laboratory parameters occurred one month after therapy onset. This improvement persisted for the whole study period. Laboratory parameters of tolerability did not change during the study. Mild to moderate steroid-related side effects occurred in 57.9% of the patients. Conclusions-Deflazacort is effective in the treatment of PMR. its long term safety profile may be superior to that of other corticosteroids.

引用

收藏

页码：331 / 333

页数：3

相关论文

共 13 条

[1] POLYMYALGIA RHEUMATICA - DURATION OF THERAPY AND LONG-TERM OUTCOME [J].

AYOUB, WT ;

FRANKLIN, CM ;

TORRETTI, D .

AMERICAN JOURNAL OF MEDICINE, 1985, 79 (03) :309-315

[2] POLYMYALGIA RHEUMATICA AND CORTICOSTEROIDS - HOW MUCH FOR HOW LONG [J].

BEHN, AR ;

PERERA, T ;

MYLES, AB .

ANNALS OF THE RHEUMATIC DISEASES, 1983, 42 (04) :374-378

[3] DEFLAZACORT VS PREDNISONE - EFFECT ON BLOOD-GLUCOSE CONTROL IN INSULIN-TREATED DIABETICS [J].

BRUNO, A ;

CAVALLOPERIN, P ;

CASSADER, M ;

PAGANO, G .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (04) :679-680

[4] POLYMYALGIA RHEUMATICA - A 10-YEAR EPIDEMIOLOGIC AND CLINICAL-STUDY [J].

CHUANG, TY ;

HUNDER, GG ;

ILSTRUP, DM ;

KURLAND, LT .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (05) :672-680

[5] A SEASONAL PATTERN IN THE ONSET OF POLYMYALGIA RHEUMATICA [J].

CIMMINO, MA ;

CAPORALI, R ;

MONTECUCCO, CM ;

ROVIDA, S ;

BARATELLI, E ;

BROGGINI, M .

ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (07) :521-523

[6] POLYMYALGIA RHEUMATICA AND TEMPORAL ARTERITIS - A RETROSPECTIVE ANALYSIS OF PROGNOSTIC FEATURES AND DIFFERENT CORTICOSTEROID REGIMENS (11-YEAR SURVEY OF 210 PATIENTS) [J].

DELECOEUILLERIE, G ;

JOLY, P ;

DELARA, AC ;

PAOLAGGI, JB .

ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (09) :733-739

[7] A DOUBLE-BLIND-STUDY OF DEFLAZACORT AND PREDNISONE IN PATIENTS WITH CHRONIC INFLAMMATORY DISORDERS [J].

GRAY, RES ;

DOHERTY, SM ;

GALLOWAY, J ;

COULTON, L ;

DEBROE, M ;

KANIS, JA .

ARTHRITIS AND RHEUMATISM, 1991, 34 (03) :287-295

[8] PROGNOSIS AND MANAGEMENT OF POLYMYALGIA RHEUMATICA [J].

JONES, JG ;

HAZLEMAN, BL .

ANNALS OF THE RHEUMATIC DISEASES, 1981, 40 (01) :1-5

[9] TREATMENT OF POLYMYALGIA RHEUMATICA AND GIANT-CELL ARTERITIS .2. RELATION BETWEEN STEROID DOSE AND STEROID ASSOCIATED SIDE-EFFECTS [J].

KYLE, V ;

HAZLEMAN, BL .

ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (08) :662-666

[10] TREATMENT OF POLYMYALGIA RHEUMATICA AND GIANT-CELL ARTERITIS .1. STEROID REGIMENS IN THE 1ST 2 MONTHS [J].

KYLE, V ;

HAZLEMAN, BL .

ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (08) :658-661